Log in  First Connection?

Oncology Imaging: Archives News of the month

Tumor size and stage assessment accuracy of MRI and ultrasound versus pathological measurements in early breast cancer patients

 Published on 08/04/2025 |  Original article (Abstract)  | Liu Yuanyuan et al. | BMC Women's Health 2025; 25(1): 157

Breast cancer is the most common cancer among women worldwide [1]. Accurate preoperative estimation of the tumor size is instrumental in tumor stage estimation, planning the treatment, and ensuring negative resection margins [2, 3]. In particular, in patients scheduled to undergo neoadjuvant chemotherapy,...

Identification of testicular cancer with T2-weighted MRI-based radiomics and automatic machine learning

 Published on 01/04/2025 |  Original article (Abstract)  | Wang Liang et al. | BMC Cancer 2025; 25(1): 563

Testicular tumors are relatively uncommon in humans, constituting approximately 1% of all male malignancies [1]. Despite its relatively low overall incidence, testicular cancer is the most common solid tumor in men aged 20 to 34 years [2]. Due to the potential for tumor metastasis and infiltration, biopsy...

Predicting anastomotic leak in patients with esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy using a nomogram based on CT radiomic and clinicopathologic factors

 Published on 25/03/2025 |  Original article (Abstract)  | Zhao Junfeng et al. | BMC Cancer 2025; 25(1): 484

Esophageal cancer is a common malignancy of the digestive tract. According to the current global cancer statistics, it has the seventh and sixth highest incidence and mortality rates, respectively [1]. Based on the CROSS and NEOCRTEC5010 studies, neoadjuvant chemoradiotherapy (NCRT) and radical esophagectomy...

Development and evaluation of a deep learning framework for pelvic and sacral tumor segmentation from multi-sequence MRI: a retrospective study

 Published on 18/03/2025 |  Original article (Abstract)  | Yin Ping et al. | Cancer imaging 2025; 25(1): 34

Pelvic and sacral tumors (PSTs) are rare and complex, posing significant challenges for diagnosis and treatment due to their anatomical location and diverse tissue characteristics [1, 2]. These tumors, whether primary or secondary, typically present as large soft tissue masses that can invade surrounding...

A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer

 Published on 11/03/2025 |  Original article (Abstract)  | Mari et al. | Prostate Cancer and Prostatic Diseases 2025; 28(1): 56-69

Positron Emission Tomography-Computed Tomography using Prostate-Specific Membrane Antigen (PSMA PET/CT) has emerged as a promising novel imaging modality in the management of prostate cancer (PCa) patients. PSMA PET/CT has been primarily applied in detecting PCa recurrence after primary treatment, and...